Table 2.
Selected examples of iCVD layers for controlled release.
| Polymer composition | As-deposited thickness (nm) | Substrate | Permeant | References |
|---|---|---|---|---|
| NEUTRAL HYDROGELS | ||||
| P(HEMA-co-EGDA) | 40 | Porous alumina membranes | Fluorescein (dye) | Ozaydin-Ince et al., 2011 |
| P(HEMA-co-EGDMA) | 30–60 | Porous alumina membranes | Phloroglucinol (dye) | Armagan and Ozaydin Ince, 2015 |
| P(HEMA-co-EGDMA) | 200 | Solid drug layer on a planar substrate | Indomethacin (pain relief) | Christian et al., 2018 |
| P(HEMA-co-EGDMA) | 200–500 | PET, cotton fabric, polycaprolactone nanofiber mats | Indomethacin (pain relief) | Ghasemi-Mobarakeh et al., 2019 |
| P(HEMA-co-EGDMA) | 200 | solid drug layer on a planar substrate | Clotimazole (antifungal) | Christian et al., 2016 |
| P(HEMA-co-EGDMA) | 1,000 | Free-standing films released from polyacrylic acid sacrificial layer | Alizarin yellow; phloroglucinol; 4-phenyldiphenylamin (dyes) | Tufani and Ince, 2015 |
| pH RESPONSIVE | ||||
| P(MAA-co-EA) | 70–400 | ibuprofen microcrystals | ibuprofen (pain relief) | Lau and Gleason, 2007 |
| P(MAA-co-EDMA) | 340 | Porous silicon loaded with drug | Camptothecin (cancer treatment) | McInnes et al., 2012 |
| P(MAA-co-EGDMA) | 200 | Solid drug layer on a planar substrate, cellulose membrane loaded with drug | Gentamicin (antibiotic) | Decandia et al., 2020 |
| P(MAA-co-EGDMA) | 200 | Solid drug layer on a planar substrate | Clotimazole (antifungal) | Christian et al., 2016 |
| P(MAA-co-EGDMA) | 200–500 | Drug loaded PET, cotton fabric, polycaprolactone nanofiber mats | Indomethacin (pain relief) | Ghasemi-Mobarakeh et al., 2019 |
| P(MAA-co-DMAAm-co-DEGDVE) | 70–500 | AAO membranes | Glucose (sugar); bovine serum albumin (protein) | Tenhaeff and Gleason, 2009 |
| P(MAH-co-MAA) (conformal) |
1,000 | Drug-loaded microporous polylactide membranes | Rifampicin (antibiotic) | Shi et al., 2018 |
| P(4VP-co-EGDMA) | 65 | Mat of polyvinyl alcohol nanofibers electrospun with RB | Rose Bengal (RB) (chemotherapeutic agent) | Sayin et al., 2019b |
| THERMALLY RESPONSIVE | ||||
| P(NIPAAm-co-EGDMA) | 30–60 | AAO template | phloroglucinol (dye) | Armagan and Ozaydin Ince, 2015 |
| P(NIPAAm-co-DEGDVE) | 200 | Porous silicon loaded with drug | Camptothecin (cancer treatment) | McInnes et al., 2016 |
| P(NIPAAm-co-DEGDVE) | 200 | Solid drug layer on a planar substrate | Clotimazole, indomethacin (pain relief) phenytoin | Werzer et al., 2019 |
| P(NVCL-co-DEGDVE) | 10–50 | Planar Eudragit layer | na | Muralter et al., 2019 |
| HYDROPHOBIC ENCAPSULATION | ||||
| P(CHMA-co-EDGMA) | 400–600 | Solid microparticles of an agrochemical | Crop protection compound | Bose et al., 2012a |
| PEGDMA | 200 | Solid drug layer on a planar substrate | Indomethacin (pain relief) | Christian et al., 2018 |
| PEGDMA | 23 | Mat of gelatin nanofibers | Gelatin | Mansurnezhad et al., 2020 |
| PPFDA | 200 | Solid drug layer on a planar substrate | Clotimazole (antifungal) | Christian et al., 2016 |